Jonathan Lehman, M.D. PhD

Dr. Lehman's current research is focused on neuroendocrine signaling and target discovery in small cell lung cancer. He is currently studying how metabolism plays an underappreciated role in SCLC and SSTR2 signaling with its role in AMPKa phosphorylation in metabolic flux and survival.